TW404834B - Pharmaceutical compositions for inhibiting endometrial cancer - Google Patents

Pharmaceutical compositions for inhibiting endometrial cancer Download PDF

Info

Publication number
TW404834B
TW404834B TW084108700A TW84108700A TW404834B TW 404834 B TW404834 B TW 404834B TW 084108700 A TW084108700 A TW 084108700A TW 84108700 A TW84108700 A TW 84108700A TW 404834 B TW404834 B TW 404834B
Authority
TW
Taiwan
Prior art keywords
compound
pharmaceutical composition
endometrial cancer
patent application
estrogen
Prior art date
Application number
TW084108700A
Other languages
English (en)
Chinese (zh)
Inventor
Susan Margaret Boss
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of TW404834B publication Critical patent/TW404834B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
TW084108700A 1994-08-22 1995-08-21 Pharmaceutical compositions for inhibiting endometrial cancer TW404834B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29385394A 1994-08-22 1994-08-22

Publications (1)

Publication Number Publication Date
TW404834B true TW404834B (en) 2000-09-11

Family

ID=23130867

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084108700A TW404834B (en) 1994-08-22 1995-08-21 Pharmaceutical compositions for inhibiting endometrial cancer

Country Status (17)

Country Link
EP (1) EP0777476A4 (fr)
JP (1) JPH10504824A (fr)
KR (1) KR970705387A (fr)
AU (1) AU688112B2 (fr)
CA (1) CA2198119A1 (fr)
CZ (1) CZ51897A3 (fr)
FI (1) FI970717A (fr)
HU (1) HUT76890A (fr)
IL (1) IL115022A (fr)
MX (1) MX9701327A (fr)
MY (1) MY113757A (fr)
NO (1) NO970783L (fr)
NZ (1) NZ292017A (fr)
RU (1) RU2161964C2 (fr)
TW (1) TW404834B (fr)
WO (1) WO1996005833A1 (fr)
ZA (1) ZA956994B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) * 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
KR20160066490A (ko) * 2014-12-02 2016-06-10 주식회사 씨앤드씨신약연구소 헤테로사이클 유도체 및 그의 용도
CN115825414B (zh) * 2023-01-09 2023-04-25 中国医学科学院北京协和医院 血液或尿液代谢标志物及其在子宫内膜癌早筛中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
JPH08512197A (ja) * 1993-04-07 1996-12-24 リガンド・ファーマシューティカルズ・インコーポレーテッド 受容体アゴニストのスクリーニング方法
IL111287A0 (en) * 1993-10-15 1994-12-29 Lilly Co Eli Methods for treating resistant neoplasms
WO1996005832A1 (fr) * 1994-08-22 1996-02-29 Eli Lilly And Company Procedes enrayant l'hyperplasie endometriale primaire
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses

Also Published As

Publication number Publication date
AU688112B2 (en) 1998-03-05
IL115022A (en) 2000-07-31
FI970717A0 (fi) 1997-02-20
AU3370095A (en) 1996-03-14
NO970783D0 (no) 1997-02-20
MY113757A (en) 2002-05-31
CA2198119A1 (fr) 1996-02-29
JPH10504824A (ja) 1998-05-12
ZA956994B (en) 1997-02-21
WO1996005833A1 (fr) 1996-02-29
NO970783L (no) 1997-02-20
EP0777476A1 (fr) 1997-06-11
KR970705387A (ko) 1997-10-09
HUT76890A (en) 1997-12-29
EP0777476A4 (fr) 1999-06-23
FI970717A (fi) 1997-02-20
RU2161964C2 (ru) 2001-01-20
MX9701327A (es) 1997-05-31
NZ292017A (en) 2000-07-28
CZ51897A3 (en) 1997-06-11
IL115022A0 (en) 1998-06-15

Similar Documents

Publication Publication Date Title
TW403649B (en) Estrogen agonists as remedies for prostate diseases and obesity
JP6138838B2 (ja) 子宮筋腫を治療するための酢酸ウリプリスタルの使用
JP2886453B2 (ja) 血糖低下剤
JP2011510949A5 (fr)
CN107468695A (zh) 以性类固醇前体组合选择性雌激素受体调节物治疗热潮红、血管舒缩症状及夜汗的技术
TW438589B (en) Pharmaceutical compositions comprising benzothiophene compounds and with or without tamoxifen or tamoxifen analogs and their use
JPH07215858A (ja) 機能障害性子宮出血を抑制する方法
EA002054B1 (ru) Способ профилактики рака молочной железы
Kamboj et al. Centchroman: A safe reversible postcoital contraceptive with curative and prophylactic activity in many disorders
TW404834B (en) Pharmaceutical compositions for inhibiting endometrial cancer
JPH07196501A (ja) 胸部疾患を抑制するための医薬組成物
US5843964A (en) Methods of inhibiting endometrial mitoses
Pray et al. Hemorrhagic diathesis of the newborn: Effect of vitamin K prophylaxis and therapy
MXPA97002148A (en) Methods to inhibit endometr mythosis
DE69520741T2 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der primären endometriumhyperplasie
Brown et al. Breast tumors in patients with hyperprolactinemia
JP2023550149A (ja) アベマシクリブと６－（２，４－ジクロロフェニル）－５－［４－［（３ｓ）－１－（３－フルオロプロピル）ピロリジン－３－イル］オキシフェニル］－８，９－ジヒドロ－７ｈ－ベンゾ［７］アヌレン－２－カルボン酸とを含む組み合わせ
JP2023516951A (ja) アルペリシブおよび６－（２，４－ジクロロフェニル）－５－［４－［（３ｓ）－１－（３－フルオロプロピル）ピロリジン－３－イル］オキシフェニル］－８，９－ジヒドロ－７ｈ－ベンゾ［７］アヌレン－２－カルボン酸を含む組合せ物
MXPA97006520A (en) Methods to inhibit the ova cancer
PL190551B1 (pl) Zastosowanie chlorowodorku raloksyfenu
CN1155840A (zh) 防治子宫内膜癌的方法

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees